Japan’s Toray Develops Biochip For 15-Minute Disease Detection
This article was originally published in PharmAsia News
Toray Industries says it has developed a device that can cut the time for detecting the presence of cancer or other diseases from days to 15 minutes. Toray said its protein biochip, for which it plans to file an approval application by the end of the fiscal year, is capable of analyzing a single drop of blood for the presence of a disease. The company relied on nanotechnology to create a chip the size of a business card containing a tube for the blood, which can be read by an analyzer. (Click here for more - a subscription may be required
You may also be interested in...
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.
Cambridge Nutraceuticals - which develops dietary supplements that have “proven clinical benefits” - has snapped up UK-based Prime Fifty to enhance its offering with products specifically designed for the over 50s.
Shanghai Henlius Biotech has begun dosing in a Phase I trial for its HLX14 planned biosimilar version of denosumab. Multiple biosimilar developers are vying to take a slice of the market for rivals to Amgen’s Xgeva/Prolia original.